Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis - Concepedia

Concepedia

Publication | Open Access

Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis

DOI Full Paper Access

64

Citations

94

References

2019

Year

Nava Ferdowsi, Molla Huq, Wendy Stevens, Marie Hudson, Mianbo Wang, Tien Tay, Jodie Burchell, Candice Rabusa, Vijaya Sundararajan, David L. Prior,

Annals of the Rheumatic Diseases

References

	Year	Citations

Page 1